Oct 28

Buried at the end of the last post — on the GQ magazine story related to Personalized Health — was a jewel of a link to a quick, four-minute streaming video from the Interleukin Genetics site. It’s simply titled, The Science Behind Interleukin Genetics

If you’ve ever pondered over how to explain to a retail customer (or a potential business associate) what the Gensona DNA tests are about and the life-long value of the information they provide, now you don’t (have to ponder). Just refer your retail customer or potential business associate to this link for a quick, easy-to-understand presentation.

The Science Behind Interleukin Genetics

****************

Still with me? Attention span longer than you  thought? (hehe) 

Beyond that, you should still know something about the Nutrilite brand and why it gives us such a unique position in the marketplace. If you don’t know how to talk about Nutrilite’s history and the just-in-time fresh fresh freshness of the organic functional-whole-food-based products you represent, here are a few more “movies” to which you can go (and take your retail customer along).

Washington State organic farm

Mexico organic farm

Brazil organic farm

Optimal Health: The Heart of the Original Brand

Lifestyle

Personalization

Nutrigenomics

Nutrilite clinical validation studies

Nutrilite research associations

SPEAKING OF AMWAY, don’t foget to watch this space for a timely and provocative three-part series coming very soon from the pen keyboard of Chuck Lia.

Blessings for a great day… :)

written by rdknyvr \\ tags: , , , , , , , , , ,

Oct 24

NOTE TO READERS: text below in bold and blue is hotlinked to additional background info.  

This new article in GQ Magazine, The Book of Me, is of keen interest in that it demonstrates how personal genomics and Personalized Health are now growing in mass market interest in general media outlets, and not just science-oriented journalism and publications.Someone in the Alticor organization had the exceptional foresight back around 2002 or 2003 to recommend an ‘angel investment’ in Interleukin Genetics, which had made some key discoveries — pre-Human Genome Project completion — which are turning out to be core to understanding how our personal genetics influences the ageing process and chronic health conditions related thereto. Interleukin was able to apply for a number of patents based on their unique discoveries and thus claim some significant IP real estate in the “land rush” around human genome research which is shaping the future of health and health care. Alticor has thus far shown good patience with their investment in Interleukin and has provided its Distributors with an unparalleled product and business development opportunity with the Gensona DNA tests, and Nutrilite’s IL-1 Heart Health supplement — the world’s first clinically validated (published in peer-reviewed and respected scientific journals) nutrigenomic supplement – with more in the Nutrilite and Interleukin research pipelines. The article in GQ is an easy read and well-written, almost in a mystery novel genre by a top-selling novelist, so your time spent reading will be enjoyable for those who don’t think they “like” science related stuff, and a joy for those of us who see the future now and can’t wait.A key quote from the article — key for me, at least: 

He [George Church, Harvard University] defends the coming revolution, comparing it to the birth of personal computing in the late 1970s. That earlier revolution was all about mass empowerment, going, he says, “from a few people in the priesthood that guarded the mainframes, to everybody.” But few people saw the potential of that revolution early on: “Just like with personal computing, until there are some compelling stories involving real products [my emphasis] the only people who are going to get what’s happening are the ones who can imagine things that aren’t yet there.”                                        

 SPEAKING OF AMWAY GLOBAL, where do you rank Personalized Health and Nutrilite Health in your list of business development priorities? Is it “hot” or is it “not” for you, and why? Second, what is Amway Global doing well to assist you in understanding and marketing the Gensona DNA tests and the Nutrilite IL-1 Heart Health, and what in your view might they do better?  Before you answer that last question, watch this video clip

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , ,

Sep 12

For those of us focusing on the Personalized Health opportunity, the following excerpt from a press release this morning definitely adds a spring to our step (see quoted section below).

 With Personalized Health — which includes Interleukin Genetics’s patent protected IP and DNA tests, which we market under the Gensona brand, and the IL-1 Heart Health supplement patented by Nutrilitewe truly have an opportunity to reshape the health care debate in North America, even more so than the politicians campaigning for election at this moment in both the US and Canada.

As of next year, 2009, that same Personalized Health opportunity will be available to our colleagues in Asia as well, when Gensona DNA tests are rolled out for markets there.

Paper Reports Value of Specific Nutritional Products is Dependent on Individual’s Genetic Make-up WALTHAM, Mass., Sept. 12

WALTHAM, Mass., Sept. 12 /PRNewswire-FirstCall/ — Researchers at
Interleukin Genetics, Inc. (Amex: ILI), today received the 12th John M. Kinney Award for Nutrition and Metabolism at the annual Congress of the European Society of Parenteral and Enteral Nutrition, in Florence, Italy. The award was given for the paper, “Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept,” which was published in Nutrition: The International Journal of Applied and Basic Nutritional Sciences (2007;23:844-852).

Kenneth Kornman, Ph.D., Chief Scientific Officer at Interleukin Genetics, and the first author on the publication, commented, “We are honored to receive the 12th

John M. Kinney Award for Nutrition and Metabolism. Many botanical and nutritional supplements claim to provide countless health benefits without being subjected to rigorous clinical study. Our paper reports a well- controlled clinical study has shown the value of specific nutritional products is dependent on an individual’s genetic make-up.” The study, a joint research effort by scientists at Interleukin Genetics and Nutrilite, a division of Alticor Inc., is one of the few controlled clinical trials that has shown the value of specific nutritional products is dependent on an individual’s genetic make-up. The data showed that a proprietary botanical supplement (Nutrilite IL1 Heart Health Supplement) could lower inflammation in individuals who tested positive for pro-inflammatory IL-1 gene variations from Interleukin Genetics’ Heart Health Genetic Test. These individuals also had elevated levels of C-reactive protein.

About Interleukin Genetics’ Heart Health Genetic Test

Interleukin Genetics’ Heart Health Genetic Test was developed to identify healthy individuals who are genetically predisposed to over-produce inflammation and are at an increased risk for an early first heart attack.

The Heart Health Genetic Test is marketed on a non-exclusive basis [edit: it became non-exclusive for us only as of last week] through Access Business Group International LLC, a division of Alticor Inc. Interleukin Genetics recently announced an agreement with Access Business Group International that will permit the expansion of Interleukin Genetics’ distribution network for such genetic tests.

About Nutrilite IL1 Heart Health Supplement

Nutrilite IL1 Heart Health Supplement, a proprietary botanical supplement, was developed to reduce inflammation in those individuals who are genetic over-producers. The Nutrilite IL1 Heart Health Supplement is currently marketed by Quixtar, Inc., a division of Alticor Inc.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics currently offers an array of Nutraceuticals and OTCeuticals(R), which are sold at the nation’s largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment.

Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit
www.ilgenetics.com.

Note, of course, that as of last week, Amway Global business owners no longer have the exclusive distribution rights to the Interleukin DNA test IP. Why? Two basic reasons:

(1) Because of Quixtar’ screwed up launch and lack of support for  the Personalized Health product portfolio and health solution two-plus years ago and ongoing. They admitted as much when management acknowledged last year that Personalized Health was the victim of a “launch and abandon” product support mentality that prevailed before Steve Liebeman came on board and took control.

(2) In the old (and growth-destroying) business model — still ‘de facto’ business practice for most – based on the “Systems”-developed and promoted ”buy from yourself and teach others to do the same,” a major product/solution portfolio like Personalized Health was doomed to fail on that count as well. This could just as well be characterized as a “lack of leadership” by organizations which claim to be devoted to teaching leadership principles.

The defining advantage Independent Business Owners still have with Personalized Health is the core “value-add proposition” which we bring to the table — the ability to educate the consumer in a field which requires consumer education to be successful. Under the new retail sales focused paradigm being driven, thankfully, by Steve Lieberman and his new team, Personalized Health finally has an opportunity to flourish, and be the breakout health solution which will take Amway Global in North America way beyond the goals set by Doug DeVos and Steve Van Andel.

 I’m driving down to Portland later today to the Spotlight showcase, and hopefully Personalized Health and Amway Wellness will be getting the “showcase profile” they deserve. With Interleukin Genetics now winning these kinds of international awards for their ground-breaking research, we expect to see Personalized Health being promoted and celebrated front and center.

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , , , , ,

Aug 05

 One more quick post before Chuck puts up the thought provoker he’s been working on!!!

Note that blue text contains a fascinating URL link which you should click on for background info; red text is for emphasis/highlight only.

I’ve recently come across a series of insightful articles about the growth potential for Online Health, and recommend you too check out Sramana Mitra’s excellent blog, Sramana Mitra On Strategy, specifically the 5 article series Web 3.0 and Online Health.

One of the reasons Sramana’s analysis is so important relates to our Online Personalized Health Questionnaire.  This to me is the KEY VALUE ADD piece to the whole Personalized Health value proposition… and critical to supporting sales of the Interleukin Genetics Gensona DNA tests and Nutrilite’s consumable supplements such as Double X and the IL-1 Heart Health Nutrigenomic supplement, and so on.

The online Personalized Health Questionnaire is confidential, it’s free, and via the recommendations made based on the Gensona tests and the lifestyle and health question modules, provides the critical link between the DNA tests, and the appropriate Nutrilite products and lifestyle and diet and behaviour modification recommendations.

The other critical differentiator for Personalized Health in the online health channel/business space, which we have and no one else does, is our direct sales business model with its emphasis on education of the consumer and each business person building a base of retail customers.

And that is why Alticor’s Transformation process is precisely what is needed in order for the company and us to surge over the next couple of years.

But the Personalized Health Questionnaire and our direct sales business model ARE the key differentiators for success against all potential competitors, including ‘23andme‘, Navigenics, DeCodeMe, and a host of other startups and wanna-be’s.

By the way, if you enjoy Sramana’s writing style as much as I do, here’s another wonderful series she has written on the “modernization” of Indian architechureAs India Builds. Her whole series on India will be of interest to any readers from India or desi backgrounds, or any who are as fascinated with that country of contrasts as I am.

Enjoy!

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , ,

Aug 05

Note that blue text contains a fascinating URL link which you should click on for background info; red text is for emphasis/highlight only.

This interview on Personal Genetics with Harvard’s George Church (with previous posting reference here), Dr. Dean Ornish, chair of Google Health’s advisory committee, and Dr. David Agus, a leading oncologist and expert in genomic medicine was done on the same day as Charlie Rose’s already posted chat with Dr. Francis Collins.

The level of discussion does not require you to have expertise, and it will help bring everyone a bit more up-to-speed in the fast-emerging field of prevention and personal genetics.

Note that much of what is discussed — especially the discussions around prevention — are very relevant to our business space — Personalized Health – including Gensona DNA tests from Interleukin Genetics, nutrigenomic supplements from Nutrilite, and Amway Wellness.

written by rdknyvr \\ tags: , , , , , , , , , , , ,

Aug 04

Those who have been around this business for more than a couple years will be delighted to hear that Dr. Chet is returning to work with Amway Global/Quixtar and The Center for Optimal Health, effective August 10th.

 Dr. Chet has spent the last several years with The Better Life Institute, more recently known as Better Life Unlimited, in Grand Rapids. Dr. Chet was a very popular educator and highly motivational speaker and trainer for all things health and nutritional. He has also had a running series of bulletins and newsletters available by free subscription from the Better Life Unlimited website which provided excellent support to people starting weight loss/managment programs.

His favorite weight management maxim is “EAT LESS, MOVE MORE.”

Examples of some of Dr. Chet’s excellent bulletins — always based on solid science and peer-reviewed research journals – are as follows:

Fountain of Youth
One Hit Wonder: Acai
The Placebo Effect
Phytonutrients: The Basics

All IBOs building Amway Wellness businesses — including Nutrilite products — and interested in “Optimal Health” and “Personalized Health” will be delighted to welcome Dr. Chet back.

written by rdknyvr \\ tags: , , , , , , , , , , ,

Aug 02

For those developing an Amway Wellness-focused business – with Gensona and Nutrilite products, and Time Defiance (Artistry Skincare) – this easy-to-understand interview with Dr. Francis Collins on the Charlie Rose Show earlier today will delight you. The interview mentions “Personalized Medicine” at various points but much of the discussion is pertinent to Personalized Health as well.

OUR FOCUS in the Personalized Health business space is on our genetic predisposition for certain health risks — usually chronic and often related to the aging process – based on our personal genomes. Using exclusive, simple-to-use DNA tests and a confidential, online Personalized Health Questionnaire, we  recommend behaviour changes (including exercise, diet, among others) and supplements, including exclusive nutrigenomic supplements to support a healthy  lifestyle and “extend your years of wellness.”

In a nutshell, that’s our business and value proposition.

For more information on this point, read Section B-1 of the current Business Reference Guide (pdf downloadable for free from our site), and Personalized Health Program Guidelines, available on the Quixtar/Amway site. (Eventually, there should be similar guidelines posted under Best Practices at the IBOAI site and blog.)

Dr. Collins was the head of the Human Genome Project — completed in 2003 – and his lab discovered the genes responsible for Cystic Fibrosis and Huntingdon’s Disease in the 1980’s.

Collins recently resigned his position at the National Institutes of Health to pursue his interests in driving Personalized Medicine research and related writing projects. August 1, 2008 was his last day at NIH.

INTERESTINGLY, Collins recently published a fascinating book on the DNA code called, “The Language of God: A Scientist Presents Evidence for Belief.”

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , ,

Jul 29

Just in case there are any genuinely committed business builders reading this blog who are building an Amway Wellness (ie. Nutrilite, Gensona, etc.), or an Amway Beauty business (which could include relevant Gensona tests at some point) this brief post will draw your attention to an interesting blog on personal genomicsgenomeboy — and an excellent new article in Wired magazine on Harvard University’s George Church and developments in genomics, sequencing and synthetic biology.

A number of personalized genomics companies are mentioned in the article — some of whom are potential competitors, but not in our direct sales channel (yet) and some who are strictly in the personalized medicine space, not the personalized health space where we (Alticor/Amway/Quixtar) are positioned. Some of these include: 23andme, funded in part by Google; Navigenics, funded in part by Kleiner Perkins; DNA Direct, Sciona, Knome, and a few others.

 By the way, in case the inclusion of references to personal genomics and synthetic biology seems far fetched, they will in short order have a major impact on our area of business interest — Personalized Health and Wellness.

Finally, if the links above to Amway Wellness and Amway Beauty seem broken, it’s because at the time of this writing AmwayWellness is registered to Weber Shandwick, a consultancy which I’m surmising has been contracted by Alticor. And the AmwayBeauty domain is registered to Alticor through MarkMonitor.

This post is an addendum to my posts on Personalized Health on this site from June 23 and July 22, and Chuck Lia’s excellent posts from March 24 and May 1, this year.

Speaking of Chuck, he has just gotten back home to Atlanta from a few days in Southern California with his family.  Watch for a thought-provoking post from him later this week on … can’t tell you but it will be good!!!

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , , , , , ,

Jul 22

Tantalizing hints about new Transformation changes have been leaking out from Alticor sources to bloggers over at Amway Talk (http://www.amwaytalk.com/) — see post on “Transformation: Major Changes Coming in September.” In addition, some have noted the registration by Alticor or its consultants of the domains Amway Wellness.com and Amway Beauty.com.

Now this morning (July 22) comes the press release below: 

WALTHAM, Mass., July 22 /PRNewswire-FirstCall/ — Interleukin Genetics, Inc. (Amex: ILI), today announced the launch of an enhanced test report format and information package for the company’s Heart Health Genetic Test. The test is currently marketed under the brand name Gensona(R) Heart Health Genetic Test by Quixtar/Amway. The new report will include quantified risk information on heart attack and coronary artery disease generated from clinical studies and conducted by the company. The company believes that this enhanced report format will provide individuals and their physicians more complete information about a person’s inflammation-based genetic risk factor for a heart attack. The new package also provides information on the science behind the genetic test and information to help people understand preventive measures and actions that can be taken to lower the risk of heart disease.

In addition, the company will conduct scientific lectures on the Gensona(R) test for interested Quixtar/Amway individual business owners at their scheduled conferences. The first of these lectures will be on Saturday morning and afternoon, July 26, 2008 at the Nardone/Melillo/Callendar conference at the Radisson Valley Forge Hotel & Convention Center in Valley Forge, PA. Thousands of attendees are expected at the conference.

Lewis H. Bender, Chief Executive Officer at Interleukin Genetics, commented, “Heart disease is by far the leading killer of Americans. Individuals with different interleukin gene variations have vastly different clinical trajectories for heart disease progression. The ability to know your individual genetic predisposition for this disease is a new and powerful tool to allow a customer and their physicians to design the best preventive care for that person.”

About Coronary Artery Disease

Coronary artery disease (CAD) is an inflammatory disease in which plaque builds up inside the coronary arteries. These arteries supply your heart muscle with oxygen-rich blood. Plaque is made up of fat, cholesterol, and other substances found in the blood. When plaque builds up in the arteries, the condition is called atherosclerosis. Variation in interleukin genes has shown to be associated with different degrees of CAD risk. Over time, CAD can weaken the heart muscle and lead to heart attack and arrhythmias. CAD is the most common type of heart disease and is the leading cause of death in the United States for both men and women. Lifestyle changes, medicines, and/or medical procedures can effectively prevent or treat CAD in most people. Certain cholesterols have also been associated with increased CAD risk. According to the American Heart Association, over 105 million American adults have total blood cholesterol values of 200 mg/dL and higher, and 36.6 million American adults have levels of 240 or above. Doctors consider total cholesterol levels of 240 mg/dL or greater high in adults and levels from 200 to 239 mg/dL borderline-high.

About Interleukin Genetics

Interleukin Genetics, Inc. (Amex: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. For more information about Interleukin, its products and ongoing programs, please visit http://www.ilgenetics.com.

SPEAKING OF AMWAY, how do you  plan to incorporate Gensona and Personalized Health into your Amway Wellness business? Will you be leading with a product opportunity to build a strong, profitable client base from which you will find others who want to build their own part-time businesses? Or will you be leading with a business opportunity and trying to redirect those who are not interested toward products and to become clients?

written by rdknyvr \\ tags: , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Jul 14

“It just seems to me you aren’t going to be credible if all you talk about is your successes.”JAMES CANALES, President and CEO of The James Irvine Foundation, one of California’s ten largest foundations

“A real leader learns ways to promote and reward truth-telling, demands honesty from his or her crew, and never punishes messengers with bad news.”C. MICHAEL ABRASHOFF, former Commander of the “Best Damn Ship in the Navy, the U.S.S. Benfold,” and the author of three New York Times bestsellers on leadership, including It’s Your Ship

Amway is currently in the first year of a major business transformation.  It goes almost without saying that all businessmen understand that turning a company like Amway North America around is no easy task and takes tremendous skill and expertise.  Well, Steve Miller is affectionately nicknamed “U.S. Industry’s Mr. Fix It” by America’s business leaders for his unparalleled success in turning around failing companies.  In 2002 the Wall Street Journal asked Miller if he would share with the Journal’s subscribers his thoughts on the most important aspects of turning a company around.  That request resulted in an article in the WSJ by Miller that same year titled “Tips From A Turnaround Specialist.  Allow me to note that Steve Miller is the former CEO of Delphi Corporation and the author of the recent book release The Turnaround Kid:  What I Learned Rescuing America’s Most Troubled Companies.  As Amway Global is in the midst of its transformation today, its turnaround if you will, I thought after reading Miller’s book that looking at Amway’s North American business transformation today in light of Miller’s seven tips might be a worthwhile online exercise.  Below is a list of Miller’s seven tips with my comments added after each tip.  I would be interested in hearing your comments about these seven tips as well.

TIPS FROM A TURNAROUND SPECIALIST by Steve Miller

1.  Tell everyone the truth, especially if the truth hurts.

This is the one issue I find most disappointing about Amway’s public image.  As James Canales says in the quote leading off this post, only bringing up the positive undermines your credibility.  Publicly owning up to challenges adds credibility to the positive things a company says.  A few weeks ago, Microsoft lost a court case.  Within hours their media and PR folks (are you listening Amway/Alticor Media Blog?) released a statement saying “we still believe in our position and expect to appeal.”  So, even when a current outcome isn’t positive Microsoft at least publicly acknowledges the current state of affairs.  Every time Amway fails to acknowledge or comment on a recent negative court ruling or public event (as has been the case multiple times this year alone) it loses a little more credibility with me and others, and it will continue to lose credibility until its actions in this area become more transparent — or I and others no longer care about Amway enough to be concerned about its failure to be fully forthcoming.  In my opinion, Amway’s failure to openly discuss negative news and outcomes shows weakness and frailty, not strength and resolve — and I believe the company is stronger and more resilient than that.  It’s well past time to demonstrate it when it comes to truth telling.

2.  Don’t study things to death.  Most of the choices you need to make are clear, and decisiveness breeds confidence.

Would anyone say Amway has been clear and decisive over the last twenty-five years?  While sometimes Tex can annoy people, one point that Tex makes is not refutable:  Amway has had more than enough time to deal with several critical issues, some of which were clearly delineated by Rich DeVos over twenty-five years ago.  The perception that Amway has failed to act decisively on those issues in the past has bred a lack of confidence in the company among many IBOs, and a general lack of credibility in the public at large.  Regardless of what Amway is doing today, it is accountable for failing to act in the past.

Please understand, I am not saying that Amway is not dealing with these issues in several meaningful ways today, but it is important for Amway corporate to remember how long some of these issues have been on the table.  It’s definitely time for Amway corporate to be very clear and very concise about where the company is headed.  I do get a sense that some real changes are being implemented and that the corporation is taking serious steps to turn things around, but clarity and ongoing communication about those changes and steps are critical.  The new national ad campaign is a meaningful step in the right direction on a public level, but there is much more that can be done on the IBO level.  The North America Spotlight Tour is an important step in that direction, clearly demonstrating the change and innovation coming from the company today.  This weekend the Tour stopped in Chicago, and bloggers Big Apple and Bridgett were both in attendance [as were AJ Gannon and bernsber!].  I’m looking forward to hearing from them online when they get home.  The recently announced sponsorship of the Tina Turner Tour by Amway Global is another terrific step in the right direction.  There is much positive to talk about in this area.

3.  Listen to your customers.  They know more about what’s wrong with your company, and what’s right, than anyone.

Who are Amway’s real customers?  Based on recently revealed data from court cases I think we would have to say it’s Amway’s IBOs.  Retail sales of only 3.5% of total volume can hardly be considered much in the way of true customer retail volume.  So the question morphs into which so-called “customers” is Amway listening to?  Better yet, which of its “customers” should Amway be listening to?  It’s IBOs?  It’s retail customers?  Both?  Neither, but “focus groups” instead?  Often it appears Amway’s so-called “focus groups’ are made up primarily of IBOs.  Think that one out, doing product marketing research with a captive clientele like starry-eyed new Platinums.  What we need instead is marketing research done with our target audience, potential customers with whom we have no leverage.

Just who is Amway doing its market research with?  I’d really like to know the answer to that question so I would have a better feel for the direction Amway is taking.  For what it’s worth, I believe if Amway wants to know what is wrong with these aspects of its business perhaps it should listen to some of the people who have refused to buy our products or decided not to join our business.  Ask them why, and then take their answers seriously.  The bottom line is that products purchased by IBOs are important to our success, but products that retail customers are willing to buy because they find them compelling and attractively priced are even more important to our long-term success.  We do not need or want discounted, low quality products.  Discounted products often say the wrong things about a company and its products.  (If you don’t believe that take a read of Chapter 10 “The Power of Price:  Why a 50-Cent Aspirin Can Do What a Penny Aspirin Can’t” in Dan Ariely’s book Predictably Irrational.)  At the same time, over-engineered (so-to-speak) products, expensively priced for our general clientele, also create serious credibility issues for us (think Tolsom Shaving Gel).  Neither discounted products nor high end, expensively priced products are the right approach.  Beyond that, developing products with the IBO in mind as the primary customer is borderline deceitful in regards to the marketing plan.  Hopefully we have learned something from the past on this issue and are not going to travel further down this road.

As an aside, IBOs are customers of Amway in a different and rather unique way:  We are asked to promote the business to other potential business owners.  So in a very real sense we are “business” customers of Amway.  We have to “buy” into the Amway business, and then effectively “promote” it to others.  We have to believe it has real value, not only to us, but to others as well, if we are going to build profitable IBO business networks that move products to end users.  How do you feel about the value of an Amway business in the marketplace today?  Personally I’d say an individual Amway business is more valuable today than it was a few years ago, and it also has greater potential than ever.  I’d also add however that it has some serious issues it needs to overcome if our company and our business opportunity are going to recapture their places as the industry leaders in North America.

4.  Listen to your people.  Consult everyone, from the boiler room at the plant to the executive suite so you become fully informed.  Invite everyone to send e-mails, and answer them!  (emphasis Miller’s)

My personal experience tells me that Amway does this decently on every level but one.  The Opportunity Zone corporate sponsored blogs have been a terrific new approach and have demonstrated Amway’s willingness to listen to everyone and anyone with virtually no censorship.  They are moderated by talented and interesting people like Robin Luymes and Beth Dornan, and have convinced me the company is open to hearing from us.  However, what these corporate blogs have not done is convince me of Amway’s willingness to allow some of its employees to discuss the truly tough issues.  It appears that when the topics get tough, Amway goes mute, and mutes its staff as well.  On some level, this needs to change.

Another area where Amway falls down in my own limited experience is in responding to inquiries for clarification, particularly if the topic raised or the question asked has a negative connotation.  This kind of goes back to Tip #1, Amway’s apparent unwillingness to speak openly about negative issues.  A few weeks ago I sent an e-mail to Amway’s Rules Department requesting feedback on a specific issue, and was promised by e-mail reply that I would receive a prompt answer.  Since then I’ve heard nothing, and it’s been over a month.  There is tremendous room for improvement in this area. As Miller admonishes, “Answer them!”

5.  Do a wardrobe check.  If people gladly wear caps and shirts with the company logo, morale is good.  If no one wants to be identified as your employee when they go to the mall, you’re in trouble.

This tip is true of IBOs in the field as well, and needs to be directed at both corporate and IBO leaders.  I would say to Steve and Doug and the new Alticor and Amway corporate staff, if you don’t see any of your IBO leaders wanting to be identified publicly as your business owners, you’re in trouble.  You tell me, have you seen any Quixtar or Nutrilite logos on the baseball hats of any Diamonds on the recreation fields of North America lately?  Or on any of the apparel of your corporate staff on a Saturday afternoon?  Have you seen any Nutrilite logo clothing on any Diamonds outside of an Amway sponsored function?  Have you seen any XS Energy logo decals on any Diamond vehicles lately?  (I have one on mine.)  By the way, those XS Energy marketing folks really get it.  They know how to promote their product and their brand.  We should do half as well as they do.

Yes, I know, IBO leaders lead with the business (”Which business?” I might ask, but I digress), that’s why they don’t wear a hat or a polo shirt with Nutrilite’s or Quixtar’s logo on it, and why they don’t have an XS decal on their car.  It’s the curiosity approach, stupid.  Yeah, I get it, that’s the reason.

Sure it is.

Can you imagine a Nike executive having any problem wearing apparel with the company logo on it?  Any Google exec having a problem with wearing her company’s logo on a sweater?  A Celtic fan?  A Harvard student?  Been to a professional golf or tennis tournament lately?  Seen any corporate logos around?  Heck, as much as it annoys me, I’ve seen dozens of vehicles around Atlanta with large MonaVie logos and contact info on their back window.  Do we want Amway to have a reputation that we can be proud of?  Let’s start by putting ourselves on the line and have everyone go public about their affiliation with the business — and that means corporate staff and IBOs.  Then we’d be forced to truly live up to the reputation we want the company to have. 

I recently made a commitment to wear warm-up jackets, shirts, baseball hats, or something else with the Nutrilite logo on it whenever possible when I give tennis lessons to my students (I am a tennis pro), so I am going to purchase some clothing with company logos on it for myself.  I have also made a commitment to tell anyone who asks me what I do for a living (and also those who don’t ask) that I am a tennis pro who is also building an Amway business, chips fall where they may.  And I know that by doing so over time I will learn how to handle their follow-up questions appropriately, effectively, and winsomely.  I’m not interested in any more “spinmeister” answers to simple questions from prospects and friends, answers that avoid providing transparent, honest, and relevant information.  So far my commitment to candor hasn’t created a single problem for me.  I am convinced one of the best ways to deal with the negative on the internet is to demonstrate the positive aspects of the business publicly on a personal level.  If we can’t do that, then we really do have a problem. As I wrote earlier in this post, the recent national ad campaign by Amway is a great step in the right direction, but it’s time for all IBOs to come out into the open and put themselves on the line too.  Right now Amway is investing huge financial and human resources trying to tell North America the real story of Amway.  An important aspect of making that investment worthwhile to Amway is having IBOs become publicly visible as representatives of the business.  Thus, when people are looking for Amway, they’ll know where they can find it and they’ll have a better feel for the quality of the people in the business.  Clearly revealing our affiliation with Amway is one way to do just that.

6.  Practice calm realism.  The key here is to stay balanced.  Truth telling can be scary, but if you let people know there are solutions for most problems, they’ll be less discouraged.

This goes back a little to my comments in point 1.  Truth telling is scary, but it’s better than hiding the truth, and all of us know that from experience.  In May, in a move unprecendented at a U.S. corporation, the top performing insurance giant, Aflac, decided on its own to give its shareholders the right to weigh in on the issue of executive compensation.  Brian Cadman, an associate professor at Northwestern University’s Kellogg School of Management said, “This is going to be a peer-pressure issue and it’s going to be the better-run firms that are going to start down this path.  Down the road, it’s going to be the type of thing to help Aflac signal that they are doing the right thing by their shareholder.”  Interestingly, Aflac is taking this step while they are not suffering from any public relations nightmares that might have required a face-saving response.  Aflac Chairman and CEO Daniel Amos at first said, “I was nervous [about the say-on-pay proposal].  I didn’t know what we were getting into.”  But the company decided to that it had to allow the shareholder vote on executive compensation to live up to its “corporate philosophy of openness.”

We’re beginning to see a return to respect for the truth from a number of large organizations.  After the Carnegie Foundation’s ill-starred efforts to help Zimbabwe overhaul its constitution and its government, for example, the foundation published a report that began, “This is the anatomy of a grant that failed.”  In addition, the Army has begun a critical self-assessmentof the miscues in Iraq to make sure they will never be repeated.  No company or institution can afford anymore to deceive itself about the truth about itself.  And that includes Amway.

As D. Michael Abrashoff wrote in his new book, It’s Our Ship:  The No-Nonsense Guide to Leadership,

“It is plainly suicidal today for any high stakes leader to reject bad news as is it were a live hand grenade and treat its messenger like a traitor…leaders in place or in training have an overwhelming incentive to encourage truth-telling by themselves and everyone who reports to them.  Sure, honesty can be dangerous, but, in the long run, dishonesty always loses.”

7.  You don’t need all new players to make a team into a winner.  Even at companies in crisis you’ll find lots of people who know their job and do it well.  Try to hold on to them.

I admit, this point falls outside my knowledge of Amway and Quixtar.  I don’t know the corporate staff at Amway all that well.  I’m sure several of you know them far better than I do and can comment on this point more intelligently than I can.  I do know that the people I have worked with at the company regarding specific needs I’ve had in the business (outside of the previously mentioned ones) have been terrific.  Everything I’ve read and heard about the new corporate leadership brought in by Alticor and Amway over the past year has been nothing less than stellar.  I would say this bodes well for the company’s future on all counts.

Obviously, after looking down this list, it appears Amway is doing very well on several of Miller’s tips.  It’s heartening to know that the company could easily rise to the occasion on a couple of the other points having to do with transparency and complete truth-telling.  All it would take is a total commitment to the three dynamics Steve Lieberman recently stated that Amway Global was committed to:  honesty, openness, and transparency.  I hope Amway’s leaders will jump in with both feet and deliver on that promise no matter how scary it might be.  I’m convinced doing so will pay off handsomely in the coming years.

Steve Miller obviously understands company turnaround dynamics far better than I do, so I take him at his word and his expertise that these are seven of the most important tips for turning around a company.  It seems to me to be a reasonable list and one worth contemplating in relation to Amway.  But, without wanting to be arrogant I would add an eighth tip to his list.  Here it is:

8.  If, at any time, you are not sure what to do next, refer back to Tip #1.  Telling the truth is always the best place to start.

Speaking of Amway, particularly in regards to Miller’s seven points, what are YOUR thoughts on what Amway and IBOs could do collaboratively to truly transform our business positively over the next few years?

written by Chuck Lia \\ tags: , , , , , , ,